HK1206015A1 - Salts of benzothiazolone compound as beta-2-adrenoceptor agonist -2- - Google Patents

Salts of benzothiazolone compound as beta-2-adrenoceptor agonist -2-

Info

Publication number
HK1206015A1
HK1206015A1 HK15106522.7A HK15106522A HK1206015A1 HK 1206015 A1 HK1206015 A1 HK 1206015A1 HK 15106522 A HK15106522 A HK 15106522A HK 1206015 A1 HK1206015 A1 HK 1206015A1
Authority
HK
Hong Kong
Prior art keywords
beta
salts
adrenoceptor agonist
benzothiazolone compound
benzothiazolone
Prior art date
Application number
HK15106522.7A
Other languages
English (en)
Chinese (zh)
Inventor
Arnaud Grandeury
Nicola Tufilli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53386469&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1206015(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1206015A1 publication Critical patent/HK1206015A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15106522.7A 2012-08-30 2015-07-08 Salts of benzothiazolone compound as beta-2-adrenoceptor agonist -2- HK1206015A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IQ23912 2012-08-30
PCT/IB2013/058109 WO2014033654A1 (en) 2012-08-30 2013-08-29 Salts of benzothiazolone compound as beta-2-adrenoceptor agonist

Publications (1)

Publication Number Publication Date
HK1206015A1 true HK1206015A1 (en) 2015-12-31

Family

ID=53386469

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106522.7A HK1206015A1 (en) 2012-08-30 2015-07-08 Salts of benzothiazolone compound as beta-2-adrenoceptor agonist -2-

Country Status (27)

Country Link
EP (2) EP3243817A1 (ko)
KR (1) KR20150047586A (ko)
CN (2) CN106146428A (ko)
BR (1) BR112015004127A2 (ko)
CA (1) CA2882877A1 (ko)
CL (1) CL2015000461A1 (ko)
CY (1) CY1120225T1 (ko)
DK (1) DK2890687T3 (ko)
EA (1) EA029946B1 (ko)
ES (1) ES2642003T3 (ko)
HK (1) HK1206015A1 (ko)
HR (1) HRP20171362T1 (ko)
HU (1) HUE033655T2 (ko)
IL (1) IL237382A0 (ko)
LT (1) LT2890687T (ko)
MA (1) MA37872A1 (ko)
MX (1) MX351741B (ko)
MY (1) MY169038A (ko)
NZ (1) NZ705319A (ko)
PE (1) PE20150465A1 (ko)
PL (1) PL2890687T3 (ko)
PT (1) PT2890687T (ko)
SA (1) SA515360076B1 (ko)
SG (2) SG11201501293PA (ko)
SI (1) SI2890687T1 (ko)
TN (1) TN2015000058A1 (ko)
WO (1) WO2014033654A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040962A1 (es) 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
CA2514733A1 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
JP2007537187A (ja) 2004-05-13 2007-12-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物
GB0426164D0 (en) * 2004-11-29 2004-12-29 Novartis Ag Organic compounds
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
AU2014222362B2 (en) * 2013-02-28 2016-07-21 Novartis Ag Formulation comprising benzothiazolone compound

Also Published As

Publication number Publication date
LT2890687T (lt) 2017-09-11
NZ705319A (en) 2018-05-25
PT2890687T (pt) 2017-10-05
BR112015004127A2 (pt) 2017-07-04
HRP20171362T1 (hr) 2017-11-03
CN104736525B (zh) 2016-08-24
SG11201501293PA (en) 2015-03-30
MX351741B (es) 2017-10-26
KR20150047586A (ko) 2015-05-04
SI2890687T1 (sl) 2017-10-30
CN104736525A (zh) 2015-06-24
TN2015000058A1 (en) 2016-06-29
PL2890687T3 (pl) 2017-11-30
MY169038A (en) 2019-02-07
EA201590452A1 (ru) 2015-07-30
MX2015002656A (es) 2015-05-20
ES2642003T3 (es) 2017-11-14
EP3243817A1 (en) 2017-11-15
HUE033655T2 (en) 2017-12-28
SA515360076B1 (ar) 2016-03-20
EA029946B1 (ru) 2018-06-29
IL237382A0 (en) 2015-04-30
WO2014033654A1 (en) 2014-03-06
SG10201704377PA (en) 2017-06-29
DK2890687T3 (en) 2017-10-09
CL2015000461A1 (es) 2015-05-04
EP2890687B1 (en) 2017-06-28
MA37872A1 (fr) 2018-07-31
CA2882877A1 (en) 2014-03-06
EP2890687A1 (en) 2015-07-08
PE20150465A1 (es) 2015-04-22
CY1120225T1 (el) 2018-12-12
CN106146428A (zh) 2016-11-23

Similar Documents

Publication Publication Date Title
EP2842955A4 (en) TRK-INHIBITING CONNECTION
EP2873669A4 (en) HETEROCYCLIC COMPOUND
EP2832734A4 (en) HETEROCYCLIC CONNECTION
AP4063A (en) Dimethyl-benzoic acid compounds
EP2818473A4 (en) HETEROCYCLIC COMPOUND
GB201220843D0 (en) Compound
EP2857400A4 (en) HETEROCYCLIC COMPOUND
ZA201500790B (en) Benzothiazolone compound
HK1203355A1 (en) Uses of 4-desferrithiocin analogs 4-
HK1214601A1 (zh) 用於製造 -標記物的新型雙-銥-配合物
EP2680843A4 (en) DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS
EP2940005A4 (en) nitrile
GB201216309D0 (en) Compound
GB201215675D0 (en) Compound
HRP20171362T1 (hr) Soli benzotiazolonskog spoja koje služe kao agonist beta-2-adrenoceptora
PL2760822T3 (pl) Sole desfezoterodyny
GB201216448D0 (en) Compound
GB201108347D0 (en) Polymprphic form of compound
GB201204590D0 (en) Prodrugs of thiazolamine compounds
GB201223187D0 (en) Formula 1- 2050
GB201222981D0 (en) Formula 1 -2050
GB201222964D0 (en) Formula 1 - 2050
GB201222716D0 (en) Compound
HUP1200574A2 (en) Use of photochemically cleavable compounds
GB201121669D0 (en) Formula 1 - 2050

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210826